Volume 21, Number 11—November 2015
Research
Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010–2013
Table 2
Isolates positive for invasive pneumococcal diseases and resistant to penicillin, macrolide, and quinolone, by genotype, Japan, April 2010–March 2013*
Genotype | Total, no. (%), N = 715 | 2010–2011, no. (%), n = 275 | 2011–2012, no. (%), n = 213 | 2012–2013, no. (%), n = 227 | p value† |
---|---|---|---|---|---|
Penicillin resistance | |||||
gPSSP | 115 (16.1) | 42 (15.3) | 40 (18.8) | 33 (14.5) | 0.431 |
gPISP (pbp2x) | 286 (40.0) | 96 (34.9) | 89 (41.8) | 101 (44.5) | 0.076 |
gPISP (pbp2b) | 9 (1.3) | 5 (1.8) | 0 | 4 (1.8) | ND |
gPISP (pbp1a+2x) | 73 (10.2) | 30 (10.9) | 23 (10.8) | 20 (8.8) | 0.701 |
gPISP (pbp1a+2b) | 4 (0.6) | 3 (1.1) | 1 (0.5) | 0 | ND |
gPISP (pbp2x+2b) | 42 (5.9) | 10 (3.6) | 11 (5.2) | 21 (9.3) | 0.025 |
gPRSP (pbp1a+2x+2b) |
186 (26.0) |
89 (32.4) |
49 (23.0) |
48 (21.1) |
0.008 |
Macrolide resistance | |||||
Resistance gene (-) | 74 (10.3) | 34 (12.4) | 16 (7.5) | 24 (10.6) | 0.216 |
mef(A) gene | 169 (23.6) | 63 (22.9) | 56 (26.3) | 50 (22.0) | 0.538 |
erm(B) gene | 407 (56.9) | 152 (55.3) | 123 (57.7) | 132 (58.1) | 0.777 |
mef(A) and erm(B) |
65 (9.1) |
26 (9.5) |
18 (8.5) |
21 (9.3) |
0.925 |
Quinolone resistance‡ | |||||
gyrA+parC | 5 (0.7) | 2 (0.7) | 3 (1.4) | 0 | ND |
parC | 9 (1.3) | 5 (1.8) | 1 (0.5) | 3 (1.3) | ND |
*Years run from April 1–March 31 of the following year. ND, not determined because of a low number of strains.
†p values characterize comparison of the 3 surveillance periods.
‡Quinolone resistance, Ser81Phe substitution in GyrA and Ser79Tyr in ParC, respectively.